Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07240636

Study of Food Effects of VV119 Capsules in Chinese Healthy Volunteers

Status
Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
16 (estimated)
Sponsor
Vigonvita Life Sciences · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study is a single-center, randomized, open label, 2×2 crossover design to assess the standard meal effects on PK of a single oral dose of VV119 in healthy adult subjects.

Conditions

Interventions

TypeNameDescription
DRUGVV119A:2 mg VV119, following an overnight fast of at least 10 hours for Period 1; 2mg VV119, administered 30 minutes after the start of a Standard meal for Period 2;
DRUGVV119B: 2mg VV119, administered 30 minutes after the start of a Standard meal for Period 1;2mg VV119, following an overnight fast of at least 10 hours for Period 2;

Timeline

Start date
2025-11-28
Primary completion
2026-10-01
Completion
2026-10-01
First posted
2025-11-21
Last updated
2025-12-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07240636. Inclusion in this directory is not an endorsement.